Home

This training program bridges clinical therapeutics, active surveillance, administrative datasets, research methods, health services and policy, pharmaceutical policy, meta-analysis, and knowledge translation to better understand choosing, using, and losing medications within the context of drug safety and effectiveness.

As drugs become more expensive and more personalized, drug policy decision-making faces new and more difficult challenges. Effective solutions to challenging post-market medication issues are more likely to be generated when looking through a broad lens. To address these challenges, there is an urgent need to train scientists who can generate research to inform better pharmaceutical treatments, practices and policies related to post-market drug safety and effectiveness.